ZNF678 Inhibitors
ZNF678 inhibitors encompass a range of chemical compounds that interfere with various signaling pathways and cellular processes to diminish the functional activity of ZNF678. One such compound, Trichostatin A, obstructs histone deacetylase, which can repress ZNF678 expression through modifications of chromatin structure. Similarly, both 5-Azacytidine and RG 108, by inhibiting DNA methyltransferases, lead to the hypomethylation of the ZNF678 gene promoter, potentially silencing its expression. Chloroquine and MG-132 disrupt cellular degradation mechanisms; Chloroquine interferes with autophagy, possibly leading to the aggregation of ZNF678, while MG132 blocks the ubiquitin-proteasome pathway, which could prevent the degradation of ZNF678, culminating in a loss of function.
Further, the PI3K/Akt signaling inhibitor LY 294002, the mTOR inhibitors rapamycin and sirolimus, and the MEK inhibitor PD 98059 could all indirectly reduce ZNF678 activity through their respective pathways. LY 294002's action on PI3K/Akt and the effects of rapamycin and sirolimus on the mTOR pathway could alter transcription factor activities, thereby decreasing ZNF678 expression. PD 98059's inhibition of the MAPK/ERK pathway might similarly downregulate ZNF678 through changes in gene expression patterns. Additionally, cyclopamine's suppression ofthe Hedgehog signaling and SB 431542's inhibition of TGF-β receptors could decrease ZNF678 activities if ZNF678 is part of these pathways. Alsterpaullone, as a cyclin-dependent kinase inhibitor, also has the potential to hinder ZNF678 function by inducing cell cycle arrest, which may affect the protein's role if it is associated with cell cycle regulation. Collectively, these inhibitors disrupt specific cellular processes and signaling pathways, leading to a targeted diminishment of ZNF678's functional activity without affecting its direct activation or expression levels.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase (HDAC) inhibitor that can alter chromatin structure and gene expression. By inhibiting HDAC, Trichostatin A can change the expression pattern of multiple genes, including downregulation of ZNF678 by affecting the acetylation status of histones associated with the ZNF678 promoter. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that leads to hypomethylation of DNA. This chemical can decrease ZNF678 expression by inducing DNA demethylation in the gene's promoter region, which might silence gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor. RG 108 can also lead to reduced expression of ZNF678 by preventing methylation of CpG islands in the gene's promoter. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
An autophagy inhibitor that might disrupt the degradation processes in cells. ZNF678, if subject to regulation by autophagic processes, would accumulate in the presence of Chloroquine, potentially leading to its functional inhibition due to protein aggregation or misfolding. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can prevent the degradation of ubiquitinated proteins, potentially leading to decreased function of ZNF678 if it is regulated by ubiquitin-proteasome pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that might indirectly decrease ZNF678 function by altering the PI3K/Akt signaling pathway, which can be involved in the regulation of various transcription factors and potentially ZNF678. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can lead to the downregulation of several genes involved in cell growth and proliferation. ZNF678 expression could be diminished as part of the wider effects of rapamycin on gene expression. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
A Hedgehog signaling pathway inhibitor that might indirectly lead to decreased ZNF678 expression if ZNF678 is involved in this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that may reduce ZNF678 expression by altering the MAPK/ERK pathway, which can regulate gene expression patterns. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
An inhibitor of the TGF-β receptor that could lead to decreased expression of genes regulated by TGF-β signaling, potentially including ZNF678 if it is influenced by this pathway. | ||||||